Healthcare provider profile · identity verified

Migdoel Vazquez Davis, MD

General Practice · ARROYO, PR · NPI 1194740704

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	1219	195
Allopurinol	Allopurinol	1124	153
Atorvastatin Calcium	Atorvastatin Calcium	624	182
Rosuvastatin Calcium	Rosuvastatin Calcium	601	195
Omeprazole	Omeprazole	507	116
Losartan Potassium	Losartan Potassium	499	140
Famotidine	Famotidine	489	95
Metformin Hcl	Metformin Hcl	425	115
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	408	85
Metoprolol Succinate	Metoprolol Succinate	398	111
Furosemide	Furosemide	393	102
Synthroid	Levothyroxine Sodium	375	70
Tamsulosin Hcl	Tamsulosin Hcl	347	56
Alendronate Sodium	Alendronate Sodium	315	49
Levothyroxine Sodium	Levothyroxine Sodium	306	58
Montelukast Sodium	Montelukast Sodium	281	75
Cilostazol	Cilostazol	245	41
Hydralazine Hcl	Hydralazine Hcl	204	60
Carvedilol	Carvedilol	198	58
Amlodipine Besylate	Amlodipine Besylate	193	68
Clopidogrel	Clopidogrel Bisulfate	188	44
Glimepiride	Glimepiride	187	47
Gemfibrozil	Gemfibrozil	175	25
Lantus	Insulin Glargine,hum.Rec.Anlog	167	29
Donepezil Hcl	Donepezil Hcl	165	27
Ezetimibe	Ezetimibe	163	49
Duloxetine Hcl	Duloxetine Hcl	156	26
Xarelto	Rivaroxaban	143	24
Fluticasone Propionate	Fluticasone Propionate	141	53
Pantoprazole Sodium	Pantoprazole Sodium	139	36
Eliquis	Apixaban	138	21
Lisinopril	Lisinopril	134	42
Baclofen	Baclofen	127	60
Sucralfate	Sucralfate	119	41
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	118	31
Sure Comfort	Syringe-Needle,insulin,0.5 Ml	114	21
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	113	17
Latanoprost	Latanoprost	113	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	112	23
Humulin N	Insulin Nph Human Isophane	111	17
Fenofibrate	Fenofibrate Nanocrystallized	108	27
Sure Comfort	Syringe And Needle,insulin,1ml	108	19
Dexamethasone	Dexamethasone	106	71
Simvastatin	Simvastatin	105	34
Valsartan	Valsartan	97	29
Hydrochlorothiazide	Hydrochlorothiazide	91	30
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	90	25
Albuterol Sulfate Hfa	Albuterol Sulfate	88	31
Prednisone	Prednisone	87	18
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	80	14
Irbesartan	Irbesartan	80	20
Oxybutynin Chloride Er	Oxybutynin Chloride	80	13
Diltiazem Hcl	Diltiazem Hcl	79	19
Pioglitazone Hcl	Pioglitazone Hcl	79	17
Diclofenac Sodium	Diclofenac Sodium	76	29
Pentoxifylline	Pentoxifylline	76	12
Warfarin Sodium	Warfarin Sodium	76	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	75	16
Finasteride	Finasteride	72	suppressed
Buspirone Hcl	Buspirone Hcl	71	19
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	71	20
Folic Acid	Folic Acid	70	18
Diclofenac Potassium	Diclofenac Potassium	69	32
Humalog	Insulin Lispro	67	14
Meclizine Hcl	Meclizine Hcl	64	23
Tolterodine Tartrate Er	Tolterodine Tartrate	64	16
Enalapril Maleate	Enalapril Maleate	62	16
Glyxambi	Empagliflozin/Linagliptin	62	suppressed
Acarbose	Acarbose	61	17
Methotrexate	Methotrexate Sodium	61	suppressed
Spironolactone	Spironolactone	59	16
Tradjenta	Linagliptin	59	suppressed
Advocate Syringes	Syringe And Needle,insulin,1ml	57	11
Metoprolol Tartrate	Metoprolol Tartrate	57	14
Brilinta	Ticagrelor	54	suppressed
Azithromycin	Azithromycin	53	42
Meloxicam	Meloxicam	52	21
Humulin R	Insulin Regular, Human	47	suppressed
Pravastatin Sodium	Pravastatin Sodium	47	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	46	34
Lumigan	Bimatoprost	46	suppressed
Levetiracetam	Levetiracetam	45	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	suppressed
Mupirocin	Mupirocin	42	31
Fenofibric Acid	Fenofibric Acid (Choline)	41	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	39	suppressed
Nitroglycerin	Nitroglycerin	39	13
Amitriptyline Hcl	Amitriptyline Hcl	38	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	38	11
Lansoprazole	Lansoprazole	38	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	38	27
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	33
Ciclopirox	Ciclopirox	37	19
Fenofibrate	Fenofibrate,micronized	37	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	36	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	35	suppressed
Nifedipine Er	Nifedipine	34	11
Timolol Maleate	Timolol Maleate	34	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Glipizide Er	Glipizide	32	12
Easy Touch	Syringe-Needle,insulin,0.5 Ml	31	suppressed
Colchicine	Colchicine	30	18
Lactulose	Lactulose	30	12
Sildenafil Citrate	Sildenafil Citrate	30	suppressed
Fosinopril Sodium	Fosinopril Sodium	29	suppressed
Febuxostat	Febuxostat	28	suppressed
Farxiga	Dapagliflozin Propanediol	27	11
Telmisartan	Telmisartan	26	suppressed
Verapamil Er	Verapamil Hcl	26	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Jardiance	Empagliflozin	25	suppressed
Bicalutamide	Bicalutamide	24	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	24	suppressed
Hydrocortisone	Hydrocortisone	24	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	20
Alphagan P	Brimonidine Tartrate	21	suppressed
Atenolol	Atenolol	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Ibandronate Sodium	Ibandronate Sodium	20	suppressed
Anastrozole	Anastrozole	19	suppressed
Celecoxib	Celecoxib	19	suppressed
Fluconazole	Fluconazole	19	12
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	19	13
Sulindac	Sulindac	19	suppressed
Acyclovir	Acyclovir	18	11
Advocate Syringes	Syringe-Needle,insulin,0.5 Ml	18	suppressed
Azathioprine	Azathioprine	18	suppressed
Levofloxacin	Levofloxacin	18	15
Dorzolamide Hcl	Dorzolamide Hcl	17	suppressed
Glipizide	Glipizide	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Sertraline Hcl	Sertraline Hcl	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Carbamazepine Er	Carbamazepine	16	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	16	suppressed
Insulin Lispro	Insulin Lispro	16	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	16	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	16	13
Tolterodine Tartrate	Tolterodine Tartrate	16	suppressed
Ciclopirox	Ciclopirox Olamine	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Enulose	Lactulose	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Nabumetone	Nabumetone	14	suppressed
Naproxen	Naproxen	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Elmiron	Pentosan Polysulfate Sodium	12	suppressed
Flurbiprofen	Flurbiprofen	12	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	12	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	11	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Galantamine Er	Galantamine Hbr	11	suppressed
Jentadueto Xr	Linagliptin/Metformin Hcl	11	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error